Diabetic CKD: metformin tops sulfonylureas for survival

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Initiation of metformin rather than a sulfonylurea reduces mortality risk in patients with type 2 diabetes (T2DM) and chronic kidney disease (CKD).

Why this matters

  • Patients with moderately-severely reduced estimated glomerular filtration rate (eGFR) experienced the largest...